Latest News
-
Trish Foundation Fellowship
Commencing January 2024 Dr Chao Zhu was awarded a $500,000 5-year Fellowship titled, “Development and implementation of a clinical score for treatment de-escalation and discontinuation from high-efficacy therapy”. Dr Zhu is working with Associate Investigators Professor Helmut Butzkueven and A/Prof Anneke van der Walt. Prior to the commencement of this important Fellowship, Professor Butzkueven said,…
-
Aptamer-based approach to therapy
Commencing January 2025, Dr Aakanksha Dixit, working with Co-applicant A/Prof Judith Greer, was awarded a 2-year Translational Research Project Grant, the title being, “An aptamer-based approach to therapy of multiple sclerosis” at the University of Queensland. The underlying reason for the development of symptoms of MS is that a material called myelin that coats the…
-
Using advanced MRI
Commencing January 2025, Dr Heidi Beadnell, University of Sydney was awarded a Translational Research Project Grant which focuses on improving the clinical specificity of MRI scan abnormalities in patients living with MS. Dr Beadnell and her team’s Translational Research Project is titled ‘Some MS lesions matter more than others: using advanced MRI to identify critical…
-
Towards clinical translation – 2026 update
Commencing January 2023, Professor Trevor Kilpatrick and Dr Vivien Li, Florey Institute of Neuroscience and Mental Health were awarded a Translational Research Project Grant titled, “Advancing tolerogenic dendritic cell therapy for multiple sclerosis toward clinical translation”. Professor Kilpatrick, Dr Li and their team aim to develop a new way to treat MS based on using…
-
Important Findings
In 2022, Dr Izanne Roos, University of Melbourne was awarded a 3-year Trish Translational Research Project Grant titled, “Personalised therapy to prevent disability in aggressive multiple sclerosis”. In the final year of her Research Project, Dr Roos’ research has focused on two key areas: predicting MS severity and understanding the benefits of high-efficacy treatments. Using…
-
Trish Foundation Fellowship – impressive progress
In December 2023, the Trish MS Research Foundation was delighted to announce the recipient of the Trish Multiple Sclerosis Research Foundation Fellowship, with immense gratitude to the Foundation’s very valued Sponsors, donors and supporters for their exceptionally generous contribution to this Fellowship. Following the Foundation’s honorary Scientific Research Committee meeting, the 5-year $500,000 Trish Multiple…
-
Towards clinical translation
Commencing January 2023, Professor Trevor Kilpatrick and Dr Vivien Li, Florey Institute of Neuroscience and Mental Health University, were awarded a 3-year Trish Translational Research Project Grant of $250,000. Professor Kilpatrick and Dr Li’s Project is titled, “Advancing tolerogenic dendritic cell therapy for multiple sclerosis toward clinical translation”. Their aim is to develop a new…
-
Promoting Remyelination in MS
Commencing January 2023, Dr Steven Petratos and Professor Paul Stupple, Monash University, were awarded a 2-year Trish Translational Research Project Grant titled, “Development of Small Molecules to Promote Remyelination in Multiple Sclerosis”. Animal models of multiple sclerosis (MS) are important to understand how brain cells die during disease and how we can target specific molecules…
-
Preventing disability
Commencing January 2022, Dr Izanne Roos was awarded a 3-year Trish Translational Research Project Grant titled, “Personalised therapy to prevent disability in aggressive multiple sclerosis”. In this Research Project Dr Roos is aiming to validate statistical models which can predict an individual’s risk of developing eight key multiple sclerosis milestones. She will then establish whether…
-
Promoting Remyelination
Commencing January 2023, Professor Paul Stupple and Dr Steven Petratos, Monash University, were awarded a 2-year Trish Translational Research Project Grant titled, “Development of Small Molecules to Promote Remyelination in Multiple Sclerosis”. Professor Stupple and Dr Petratos are working on developing a small molecule-based treatment to reverse progressive MS through promoting remyelination of neurons. They…